—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Bio-Techne Corp (TECH) — chart, structure and Closelooknet read

The Closelooknet read

Bio-Techne makes reagents, instruments and diagnostic kits used in life science research and clinical testing, from cytokines and antibodies to spatial-biology and genomic assay tools. It splits its business into Protein Sciences and Diagnostics and Spatial Biology, selling to labs, hospitals and biotech developers worldwide.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Research diary readings, not advice.

Pick a ticker to load its detail page.

Charts from the desk on TECH

The charts this diary drew or picked on Bio-Techne Corp, as published — each dated and linked to the piece that explains it.

Signals for this name

Every Closelooknet reading that exists for TECH, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 44/100 · S&P 500 fund at 48, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-05
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 73th percentile of the window, -21.7% over 20 sessions. Factor regime → 2026-11-04
  • Sovereign pressure Index -2.05 · down 2.95 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-05
How it trades on rate days beta 0.50 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How TECH has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.50 — shows only a loose link to bond moves for every 1% move in TLT (20+ year Treasuries), Bio-Techne Corp moved 0.50% on average · correlation 0.11 · higher than 45% of US names
  • Beta, last 3 months 0.04 less rate-sensitive lately than over the year
  • On the 10 worst bond days −0.24% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +0.07% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Biotechnology · United States · 8 names with week and year-to-date

Peer group

Biotechnology · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against TECH on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Bio-Techne Corp

TECH in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Bio-Techne makes reagents, instruments and diagnostic kits used in life science research and clinical testing, from cytokines and antibodies to spatial-biology and genomic assay tools. It splits its business into Protein Sciences and Diagnostics and Spatial Biology, selling to labs, hospitals and biotech developers worldwide. It is based in Minneapolis and was known as Techne before it took its current name.
Where it sits in the stack
Bio-Techne sits outside our AI build-out index; it belongs to the healthcare and life-science tools sleeve of the wider universe, supplying the reagents and instruments that research and diagnostic labs use rather than any part of the compute or data-centre chain.
Who it is priced against
No formal peer group is set for this name in our system; the comparison the market draws is with the larger life-science tools suppliers such as Thermo Fisher Scientific, which sells similar reagents and instruments at greater scale.
Why Closelooknet tracks it
Its only seat is in the S&P 500; it carries no Closelooknet score yet, and the diary has not quoted it in any edition.
What the diary watches
Whether growth in the Diagnostics and Spatial Biology segment keeps outpacing the older Protein Sciences business as labs shift spend toward genomic and spatial tools.

Bio-Techne Corp (TECH) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: price target by Wells Fargo, 2026-08-13

The Street on this name

Analyst actions and the latest print for TECH from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Wells Fargo — target 73 Target set to $73 (+1.1% to spot) 2026-08-13

1 action on the analyst wire since 2026-08-13: 1 target change. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 0.55%, quarterly · last 0.0800 USD on 2026-08-24

Dividends and capital return

What TECH pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 0.40 USD per share · a 0.55% yield on the 2026-11-05 close 5 distributions, paid quarterly 2026-11-05
  • Change on the year +25.0% against the prior twelve months prior twelve months 0.32 USD per share
  • Last distribution 0.0800 USD per share as the price series records it, within days of the ex-date 2026-08-24
  • By calendar year 2023: 0.0800 USD (partial) · 2024: 0.32 USD · 2025: 0.32 USD · 2026: 0.32 USD to date first distribution recorded in the three-year window: 2023-11-09

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-06

Quick answers

What is Bio-Techne Corp (TECH)?

Bio-Techne Corp trades as TECH on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-11-06.

Is TECH in a Closelooknet index?

Not currently — Bio-Techne Corp is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-06.

Where does TECH trade against its moving averages?

Bio-Techne Corp trades 0.3% above its 50-day and 15.0% above its 200-day moving average (0.1% above its 20-day). As of 2026-11-05 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Bio-Techne Corp compare with its peers?

Against its peer group (Biotechnology · United States), Bio-Techne Corp (TECH) sits 0.2% below its 52-week high, 0.3% above its 50-day average; Moderna Inc (MRNA) is 7.4% below, Exelixis Inc (EXEL) is 6.8% below, Royalty Pharma Plc (RPRX) is 3.2% below, as of 2026-11-05. Put any of them next to TECH in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Bio-Techne Corp trade when bond yields rise?

Over the past year Bio-Techne Corp had a beta of 0.50 to TLT, the long-dated Treasury fund — it shows only a loose link to bond moves, higher than 45% of US names. On the 10 sessions in which long bonds fell most it moved −0.24% on average, against −0.74% for the S&P 500. As of 2026-11-05; The "How it trades on rate days" block on this page carries the lines.

What does Bio-Techne Corp do?

Bio-Techne makes reagents, instruments and diagnostic kits used in life science research and clinical testing, from cytokines and antibodies to spatial-biology and genomic assay tools. It splits its business into Protein Sciences and Diagnostics and Spatial Biology, selling to labs, hospitals and biotech developers worldwide. It is based in Minneapolis and was known as Techne before it took its current name. No formal peer group is set for this name in our system; the comparison the market draws is with the larger life-science tools suppliers such as Thermo Fisher Scientific, which sells similar reagents and instruments at greater scale. (Company snapshot of 2026-09-17.)

Where does Bio-Techne Corp sit in the AI build-out?

Bio-Techne sits outside our AI build-out index; it belongs to the healthcare and life-science tools sleeve of the wider universe, supplying the reagents and instruments that research and diagnostic labs use rather than any part of the compute or data-centre chain. Its only seat is in the S&P 500; it carries no Closelooknet score yet, and the diary has not quoted it in any edition. (Company snapshot of 2026-09-17.)

Does Bio-Techne Corp pay a dividend?

Bio-Techne Corp has paid 0.40 USD per share over the last twelve months, paid quarterly, a trailing yield of 0.55% on the 2026-11-05 close; the last distribution recorded in the price series was 0.0800 USD on 2026-08-24. As of 2026-11-05; the "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Bio-Techne Corp recently?

The most recent analyst action on Bio-Techne Corp on the Closelooknet wire is a price target by Wells Fargo on 2026-08-13 (target 73). 1 action on the analyst wire since 2026-08-13: 1 target change. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for TECH, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.